Global tuberculosis drug development pipeline: the need and the reality

This publication has 71 references indexed in Scilit:

• New vaccines for tuberculosis
  The Lancet, 2010
• Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
  The Lancet, 2010
• Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
  Proceedings of the National Academy of Sciences, 2009
• Long term efficacy of DOTS regimens for tuberculosis: systematic review
  BMJ, 2008
• Treatment Outcomes of Patients with HIV and Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2007
• Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis
  Clinical Infectious Diseases, 2005
• The action of antituberculosis drugs in short-course chemotherapy
  Published by Elsevier ,2004
• Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
  American Journal of Respiratory and Critical Care Medicine, 2003
• Interactions among Drugs for HIV and Opportunistic Infections
  New England Journal of Medicine, 2001
• Studies in Short-Course Chemotherapy for Tuberculosis
  Chest, 1981